Skip to main content

EvokAI to acquire Advancience

| News

EvokAI to acquire Advancience


EvokAI Creative Labs Inc. has agreed a deal to acquire Advancience. The diagnosis profiles enhanced by Artificial Intelligence (AI) developed by Advancience can be used to help monitor cognitive alterations with the aid of computer games. This should make it easier to diagnose neurodegenerative diseases such as Alzheimer’s at an early stage.

EvokAI Creative Labs is taking over Advancience AG as part of a deal announced by the AI-powered medtech firm. Both companies are based in Allschwil in the canton of Basel-Landschaft.

EvokAI is building a platform for brain health and recovery. “Our concept is aimed at measuring the invisible”, comments Alejandro Antalich, co-founder of EvokAI, in the press release. “It is also tremendously important to be able to spot arising problems as soon as possible; knowing what’s typical is the most important foundation to know if something is out of the ordinary”, he adds.

The acquisition of Advancience brings the company one step closer to bridging the gap between neuroscience and AI. As part of EvokAI’s expansion plan, the takeover of Advancience will enable it to combat Alzheimer’s.

Advancience participated in DayOne Accelerator

Advancience is working with the University of Basel. The company offers digital, fully automated tests, in which it integrates gaming elements. By simulating various scenarios, these can be regarded as a “perfect tool to probe, assess and even predict human behavior”, the press release states.

DayOne, the Basel-based startup accelerator for the life sciences sector, is a partner of both EvokAI and Advancience. DayOne and Basel Area Business & Innovation, the investment and innovation promotion agency, awarded Advancience one of the three startup spots for its DayOne Accelerator program at Technologiepark Basel in 2019, supporting it with a grant of 70,000 Swiss francs in the process.

Learn what it’s like to work in Switzerland, what permits you need as a foreign worker and how to find work here. Check out our working in Switzerland page for more info.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.